Company intelligence
CSL
About CSL
CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our businesses, CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. See our community guidelines: https://bit.ly/3Bs17Ra
Verified activity
Signals from CSL
11 published signals
Products & Services
CSL launched the PharmAI Pro Marketing Track built on AI-powered enterprise assistant capabilities.
Reported by Michal Lubas
People
CSL is hiring a Regional Account Manager covering the top IDNs in Connecticut, New York State, and Vermont.
Reported by Bob Miller
Research & Knowledge
CSL published an earlier study showing that first-draft time fell from about 100 hours to under four hours for Takeda's regulatory writing across 14 active programs.
Reported by Christopher M. McSpiritt
Legal & Regulatory
CSL announced that the FDA granted accelerated approval to camizestrant plus a CDK4/6 inhibitor for certain patients with HR+/HER2− advanced breast cancer with an emerging ESR1 mutation detected through ctDNA.
Reported by Mohsen Fathi
Presence & Recognition
CSL is participating in the U.S. Biotech Day 2026 panel discussion on AI in Clinical Trials.
Reported by Imran Rashid
Strategy & Corporate Development
CSL is launching a new product line for the next generation of smart home devices.
Reported by William Maung Tay, Ph.D.
People
CSL is hiring an Associate Director, Medical Affairs – Immunology to shape medical strategy, engage with KOLs, drive evidence generation, and support innovative therapies across the global post-launch lifecycle.
Reported by Jamie O'Malley
People
CSL recognized Dan Wible as Advisory Group Member and Co-Chair of the Awards & Honors Committee for the ASSP Western Pennsylvania Chapter.
Reported by Jocelyn Milby, CSP
Legal & Regulatory
CSL Level 7 laboratories in Melbourne, Australia, achieved mygreenlab certification at the Silver level
Reported by CSL
Research & Knowledge
CSL published its 2026 Annual Report detailing its efforts to strengthen the company, improve performance, and build a stronger foundation for sustainable growth.
Reported by CSL
Research & Knowledge
CSL published a 2026 study in the Journal of Medical Internet Research exploring what patients and caregivers want from generative AI-supported clinical decision tools.
Reported by Sonia Malo-Alvarez, MBEE